Er Therapeutics Stock Alpha and Beta Analysis

PNGM Stock  USD 0.0001  0.00  0.00%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Er Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Er Therapeutics over a specified time horizon. Remember, high Er Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Er Therapeutics' market risk premium analysis include:
Beta
0.0
Alpha
0.0
Risk
0.0
Sharpe Ratio
0.0
Expected Return
0.0
Please note that although Er Therapeutics alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Er Therapeutics did 0.00  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Er Therapeutics stock's relative risk over its benchmark. Er Therapeutics has a beta of 0.00  . The returns on DOW JONES INDUSTRIAL and Er Therapeutics are completely uncorrelated. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Er Therapeutics Backtesting, Er Therapeutics Valuation, Er Therapeutics Correlation, Er Therapeutics Hype Analysis, Er Therapeutics Volatility, Er Therapeutics History and analyze Er Therapeutics Performance.
To learn how to invest in PNGM Stock, please use our How to Invest in Er Therapeutics guide.

Er Therapeutics Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Er Therapeutics market risk premium is the additional return an investor will receive from holding Er Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Er Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Er Therapeutics' performance over market.
α0.00   β0.00

Er Therapeutics expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Er Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how Er Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Er Therapeutics Market Price Analysis

Market price analysis indicators help investors to evaluate how Er Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Er Therapeutics shares will generate the highest return on investment. By understating and applying Er Therapeutics stock market price indicators, traders can identify Er Therapeutics position entry and exit signals to maximize returns.

Er Therapeutics Return and Market Media

The median price of Er Therapeutics for the period between Wed, Sep 25, 2024 and Tue, Dec 24, 2024 is 1.0E-4 with a coefficient of variation of 0.0. The daily time series for the period is distributed with a sample standard deviation of 0.0, arithmetic mean of 0.0, and mean deviation of 0.0. The Stock received a lot of media exposure during the period.
 Price Growth (%)  
       Timeline  
1
Why Is Chronic Disease-Focused Jasper Therapeutics Stock Trading Higher On Monday - Benzinga
10/14/2024
2
OLMA - Olema Pharmaceuticals, Inc. Latest Stock News Market Updates - StockTitan
11/06/2024
3
Trevi Therapeutics Announces Positive Topline Results from Human Abuse Potential Study of Oral Nalbuphine - Quantisnow
12/03/2024

About Er Therapeutics Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including PNGM or other stocks. Alpha measures the amount that position in Er Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Er Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Er Therapeutics' short interest history, or implied volatility extrapolated from Er Therapeutics options trading.

Build Portfolio with Er Therapeutics

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Er Therapeutics is a strong investment it is important to analyze Er Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Er Therapeutics' future performance. For an informed investment choice regarding PNGM Stock, refer to the following important reports:
Check out Er Therapeutics Backtesting, Er Therapeutics Valuation, Er Therapeutics Correlation, Er Therapeutics Hype Analysis, Er Therapeutics Volatility, Er Therapeutics History and analyze Er Therapeutics Performance.
To learn how to invest in PNGM Stock, please use our How to Invest in Er Therapeutics guide.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Er Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Er Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Er Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...